Illumina, Inc. (ILU.F)
| Previous close | 93.17 |
| Open | 92.68 |
| Bid | 95.33 x 10000 |
| Ask | 96.03 x 10000 |
| Day's range | 92.68 - 92.68 |
| 52-week range | 85.62 - 200.00 |
| Volume | |
| Avg. volume | 16 |
| Market cap | 15.343B |
| Beta (5Y monthly) | 1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of its latest research being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 31–June 4 in Chicago. Highlights include data from several studies in partnership with Labcorp, a global leader of innovative and comprehensive laboratory services; research with Sarah Cannon Research Institute (SCRI) demonstrating further evidence to support the use of com
- PR Newswire
Illumina releases 2023 Corporate Social Responsibility Report
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its fifth annual Corporate Social Responsibility (CSR) Report. The report highlights the company's ongoing commitments and progress made in 2023 toward advancing human health by serving as a champion for patients, communities, employees, and the planet.
- PR Newswire
Anna Richo joins Illumina's Board of Directors
Illumina, Inc. (NASDAQ: ILMN) announced today that Anna Richo has joined the company's Board of Directors following shareholder approval of the director slate at the company's May 16, 2024, annual meeting. Ms. Richo currently serves as Corporate Senior Vice President, Strategic Advisor to the General Counsel and CEO at Cargill, Inc. a global food production and agricultural company.
